Form D — ESTRIGENIX THERAPEUTICS, INC.
0002141466-26-000001 · filed Jul 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $2,000,000
- Reported amount sold
- $1,000,000
- Minimum investment
- $150,000
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- ESTRIGENIX THERAPEUTICS, INC.
- CIK
- 2141466
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1225 DISCOVERY PKWY
WAUWATOSA, WI 53226 - Phone
- (262) 409-1484
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Daniel Sem · Executive OfficerWauwatosa, WI Find on LinkedIn ↗
-
William Donaldson · Executive OfficerWauwatosa, WI Find on LinkedIn ↗
-
Karyn Frick · Executive OfficerWauwatosa, WI Find on LinkedIn ↗
-
Patricia Scheller · DirectorWauwatosa, WI Find on LinkedIn ↗
-
Victoria Zellmer · Executive OfficerWauwatosa, WI Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗